Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Dextroamphetamine recalled?

Yes — there is an active recall. 7 ongoing FDA recalls mention Dextroamphetamine (48 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Dextroamphetamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Dextroamphetamine recalls on record

none so far in 2026; 48 on record, newest first
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 60687-154-25 D-1485-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-943-25 D-1484-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 60687-133-25 D-1483-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-936-25 D-1482-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-874-25 D-1481-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0555-0972-02 D-0566-2016
Class II · Moderate risk

Dextroamphetamine Sulfate Tablets

Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0555-0953-02 D-1408-2014
Class II · Moderate risk

Teva Dextroamphetamine Saccharate

CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg were manufactured using unapproved material: the finished product was not properly quarantined as rejected due to inadequate cleaning of equipment.

Terminated Unapproved drug Teva Pharmaceuticals USA NDC 0555-0972-02 D-1094-2014
Class II · Moderate risk

Dexedrine¿

Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.

Terminated Dissolution failure Amedra Pharmaceuticals LLC NDC 52054-514-09 D-385-2014
Class III · Low risk

Dextroamphetamine Saccharate

Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications. All other test specifications were met.

Terminated Dissolution failure Actavis Elizabeth LLC NDC 0228-3063-11 D-190-2013